Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antibiotic and antimicrobial agents > Cefotaxime Sodium
Cefotaxime Sodium
Inquiry
| Post Date: | Oct 11,2018 |
| Expiry Date: | Apr 09,2019 |
| Detailed Description: |
Cas No. :64485-93-4
Payment Method: T/T D/A D/P L/C 64485-93-4 Cefotaxime sodium Pass GMP USP34 Molecular Formula:C16H16N5NaO7S2 Molecular Weight:477.44CAS:64485-93-4 EINECS:264-915-9 Appearance: This product is white, almost white or yellowish white crystalline powder; odorless or slight special smell. It is free soluble in water, slightly soluble in ethanol, insoluble in chloroform. Indications and Usage: Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints; treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms; perioperative prophylaxis. ITEMS SPECIFICATION RESULTS Appearance White to pale yellow Crystalline Powder Passed Identification IR Spectrum HPLC RT Sodium Passed Passed Passed Clarity Clear Passed Color of Solution NMT 0.2(430mm,10% solution) Passed Specific optical rotation +56°~+64° +61° PH 4.5~6.5 5.5 Loss on drying ≤3.0% 2.7% Chromatographic purity Individual impurity Total impurity ≤1.0% ≤3.0% ≤0.6% ≤2.0% Sterility Sterile Passed Bacterial Endotoxins NMT 0.20 USP EU/mg Passed Particulate matter ≥10um NMT 6000 ≥25 um NMT 600 Passed Passed Assay(HPLC) 916-964μg/mg 940μg/mg Storage Condition Preserve in tight container. |
| CAS Registry Number: | 64485-93-4 |
| Synonyms: | ;Cefotaxime sodium salt;Cefotaxime sodium;Claforan;sodium salt of 7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7 (Z)-(O-methyloxime), acetate (ester);(6r-(6alpha,7beta(z)))-3-((acetyloxy)methyl)-(((2-amine-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid monosodium salt;sodium (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-, sodium salt, (6R,7R)- (1:1);cefotaxim sodium; |
| Molecular Formula: | C16H17N5NaO7S2 |
| Molecular Weight: | 478.4547 |
| Molecular Structure: | 
|
| Company: | Sinoright International Trade Co. Ltd. [ China ] |
| Contact: | Harry Du |
| Tel: | 0086-411-86596755 39210844 130 |
| Fax: | 0086-411-86596060 39210855 |
| Email: | harry.du@sinoright.net |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
-
- Sulfanilamide
- m-Methyl Benzonic Acid
- N,O-Bis(trimethylsilyl)ace...
- Methanesulfonyl chloride
- zirconium acetate
- zircon isocaprylate
- DISPERSE RED 73
- DISPERSE VIOLET 57
- DISPERSE VIOLET 77
- DISPERSE YELLOW 211
- FAST RED B BASE
- zirconium sulphate
- CATIONIC BLACK FDL
- DISPERSE RED 152
- Levamisole
- Levofloxacin
- Lidocaine HCl
- Lincomycin HCl
- Lomefloxacin HCl
- Indomethacin
- Isotretinoin
- Ivermectine
- Ketoprofen
- Ketotifen Fumarate
- Lorsartan Potassium
